Families' lived experience one year after a child was diagnosed with type 1 diabetes

Anne Wennick1, Inger Hallström

  • 1Division of Nursing, Department of Health Sciences and The Vårdal Institute, The Children's University Hospital, Lund University, Lund, Sweden. anne.wennick@med.lu.se

Insights

Families with a child newly diagnosed with type 1 diabetes find life is ordinary yet different, balancing health with invisible illness and confidence with insecurity. Healthcare should tailor support to individual family needs.

Area of Science:

  • Pediatric Endocrinology
  • Family Health
  • Psychosocial Aspects of Chronic Illness

Background:

  • Type 1 diabetes incidence is rising globally, particularly in younger children.
  • Intensive diabetes management disrupts family life and requires significant behavioral adaptation.
  • Limited research exists on the holistic lived experiences of families managing childhood type 1 diabetes.

Purpose of the Study:

  • To explore the lived experiences of families one year after a child's type 1 diabetes diagnosis.
  • To understand the multifaceted challenges and adaptations families face.
  • To provide insights for improved family-centered diabetes care.

Main Methods:

  • Hermeneutic phenomenological study design.
  • Interviews conducted one year post-diagnosis.
  • 11 Swedish-speaking families with children aged 9-14 years participated.

Main Results:

  • Families described their lives as 'ordinary yet different'.
  • Key themes included: acceptance vs. frustration, perceived health vs. invisible illness, independence vs. supervision, and confidence vs. insecurity.
  • Experiences were neither extremely difficult nor easy compared to pre-diagnosis life.

Conclusions:

  • Healthcare professionals should leverage family expertise to address specific needs, especially during blood sugar fluctuations.
  • Health-promoting collaborations must be individualized and integrated into the family's daily life.
  • Recognizing the paradoxical experiences of families is crucial for effective support.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...